Neoadjuvant chemotherapy increases the 5-year overall survival of patients with resectable cervical cancer: A systematic review and meta-analysis.

[1]  Xiaomao Li,et al.  Neoadjuvant Chemotherapy Followed by Radical Surgery versus Radiotherapy (with or without Chemotherapy) in Patients with Stage IB2, IIA, or IIB Cervical Cancer: A Systematic Review and Meta-Analysis , 2020, Disease markers.

[2]  Shan Liu,et al.  Comparison of survival outcomes of neoadjuvant therapy and direct surgery in IB2/IIA2 cervical adenocarcinoma: a retrospective study , 2020, Archives of Gynecology and Obstetrics.

[3]  G. Scambia,et al.  Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: A systematic review and meta-analysis. , 2019, Cancer treatment reviews.

[4]  Chunhong Hu,et al.  Neoadjuvant chemotherapy plus surgery versus concurrent chemoradiotherapy in stage IB2-IIB cervical cancer: A systematic review and meta-analysis , 2019, PloS one.

[5]  H. Kajiyama,et al.  The role of additional hysterectomy after concurrent chemoradiation for patients with locally advanced cervical cancer , 2019, International Journal of Clinical Oncology.

[6]  L. Si,et al.  Neoadjuvant chemotherapy does not improve the prognosis and lymph node metastasis rate of locally advanced cervical squamous cell carcinoma , 2019, Medicine.

[7]  K. Machado,et al.  Neoadjuvant Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation Versus Chemoradiation for Locally Advanced Cervical Cancer: A Randomized Phase II Trial. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Ming Wu,et al.  Neoadjuvant chemotherapy followed by radical hysterectomy for stage IB2-to-IIB cervical cancer: a retrospective cohort study , 2019, International Journal of Clinical Oncology.

[9]  Lirong Zhu,et al.  Effect of neoadjuvant chemotherapy followed by radical surgery for FIGO stage IB2/IIA2 cervical cancer , 2019, Medicine.

[10]  Shu-li Yang,et al.  Neoadjuvant chemotherapy with radical surgery vs radical surgery alone for cervical cancer: a systematic review and meta-analysis , 2019, OncoTargets and therapy.

[11]  Kathleen R. Cho,et al.  Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

[12]  Chien-Hsing Lu,et al.  Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy. , 2018, Journal of the Formosan Medical Association = Taiwan yi zhi.

[13]  T. Enomoto,et al.  Postoperative chemotherapy for node-positive cervical cancer: Results of a multicenter phase II trial (JGOG1067). , 2018, Gynecologic oncology.

[14]  M. Thakur,et al.  Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  H. Kitchener,et al.  Cervical cancer: A global health crisis , 2017, Cancer.

[16]  Si-meng Jiao,et al.  Effect of preoperative radiotherapy on stage IB2 and IIA2 cervical cancer: A retrospective cohort study. , 2016, International journal of surgery.

[17]  Hailin Wang,et al.  Efficacy of neoadjuvant chemotherapy plus radical surgery in patients with bulky stage II cervical squamous cell carcinoma: A retrospective cohort study. , 2016, International journal of surgery.

[18]  K. Keum,et al.  Neoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer , 2016, Journal of gynecologic oncology.

[19]  Jiang Yu,et al.  The efficacy and safety of neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer: A randomized multicenter study. , 2016, Gynecologic oncology.

[20]  Z. Peng,et al.  Safety and Efficacy of Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Radical Surgery Alone in Locally Advanced Cervical Cancer Patients , 2016, International Journal of Gynecologic Cancer.

[21]  Jinghong Zhu,et al.  Neo‐adjuvant chemotherapy plus surgery versus surgery alone for cervical cancer: Meta‐analysis of randomized controlled trials , 2016, The journal of obstetrics and gynaecology research.

[22]  S. Mocellin,et al.  Sentinel node biopsy performance after neoadjuvant chemotherapy in locally advanced breast cancer: A systematic review and meta‐analysis , 2016, International journal of cancer.

[23]  N. Colombo,et al.  Neoadjuvant chemotherapy in cervical cancer: an update , 2015, Expert review of anticancer therapy.

[24]  Shanshan Yang,et al.  Neoadjuvant chemotherapy followed by radical surgery as an alternative treatment to concurrent chemoradiotherapy for young premenopausal patients with FIGO stage IIB squamous cervical carcinoma , 2015, Tumor Biology.

[25]  Chunlin Chen,et al.  The efficacy of neoadjuvant chemotherapy in different histological types of cervical cancer. , 2014, Gynecologic oncology.

[26]  Yangde Zhang,et al.  Detection of cell apoptosis in pelvic lymph nodes of patients with cervical cancer after neoadjuvant chemotherapy , 2014, The Journal of international medical research.

[27]  Shi-ping Liu,et al.  Efficacy of neoadjuvant cisplatin and 5-flourouracil prior to surgery in FIGO stage IB2/IIA2 cervical cancer. , 2014, Molecular and clinical oncology.

[28]  T. Kasamatsu,et al.  Reply: ‘Comment on Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)' , 2013, British Journal of Cancer.

[29]  H. Cai,et al.  Efficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: an international collaborative meta-analysis. , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[30]  C. Ren,et al.  Comparison of clinical efficacy of three different neoadjuvant approaches (chemotherapy combined vaginal intracavitary irradiation, neoadjuvant chemotherapy alone or radiotherapy) combined with surgery for patients with stage Ib2 and IIa2 cervical cancer. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[31]  J. Tierney,et al.  Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer. , 2012, The Cochrane database of systematic reviews.

[32]  Z. Peng,et al.  Clinical evaluation of neoadjuvant chemotherapy followed by radical surgery in the management of stage IB2–IIB cervical cancer , 2012, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[33]  N. Yaegashi,et al.  Efficacy of neoadjuvant chemotherapy followed by radical hysterectomy in locally advanced non-squamous carcinoma of the uterine cervix: a retrospective multicenter study of Tohoku Gynecologic Cancer Unit. , 2012, European journal of gynaecological oncology.

[34]  D. Shen,et al.  Neoadjuvant chemotherapy for locally advanced cervical cancer reduces surgical risks and lymph-vascular space involvement , 2011, Chinese journal of cancer.

[35]  Ming-zhu Yin,et al.  The Long-Term Efficacy of Neoadjuvant Chemotherapy Followed by Radical Hysterectomy Compared With Radical Surgery Alone or Concurrent Chemoradiotherapy on Locally Advanced-Stage Cervical Cancer , 2010, International Journal of Gynecologic Cancer.

[36]  B. Mossa,et al.  Follow-up in a long-term randomized trial with neoadjuvant chemotherapy for squamous cell cervical carcinoma. , 2010, European journal of gynaecological oncology.

[37]  Juan F. García,et al.  The current role of neoadjuvant chemotherapy in the management of cervical carcinoma. , 2008, Gynecologic oncology.

[38]  H. Ayatollahi,et al.  Neoadjuvant chemotherapy and radical surgery compared to radical surgery alone in bulky stage IB-IIA cervical cancer. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[39]  H. Cai,et al.  Randomized study of preoperative chemotherapy versus primary surgery for stage IB cervical cancer , 2006, The journal of obstetrics and gynaecology research.

[40]  S. Waggoner.  Cervical cancer , 2003, The Lancet.

[41]  F. Landoni,et al.  Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  M. Tomita,et al.  Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcinoma of the cervix. , 2001, Gynecologic oncology.

[43]  Y. Soong,et al.  Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  G. Scambia,et al.  Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. , 1998, European journal of cancer.

[45]  J. Sardi,et al.  Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri. , 1990, Gynecologic oncology.

[46]  G. Gasparini,et al.  A pharmacological rationale for neoadjuvant chemotherapy with adriamycin in locally advanced breast cancer. , 1990, Anticancer research.

[47]  M. Peluffo,et al.  A possible new trend in the management of the carcinoma of the cervix uteri. , 1986, Gynecologic oncology.